Skip to main content

Table 2 GIPAP enrolment by age groups

From: Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor

GIPAP Enrollment by Age Groups

Age groups

No of patients

< 20

13

21-30

16

31-40

31

41-50

23

51-60

13

61-70

8

71-80

2

Total

106